Search research articles
Contact Us
Filters
Showing results (81-90 of 188) with videos related to
Page
of 19
Sort By:
Leukemia Research
|
May 5, 2001
Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia
J K Waselenko, M R Grever, C A Shinn, et al.
Cancer
|
May 15, 1996
Anaphylactoid reactions to methotrexate
S A Alkins, J C Byrd, S K Morgan, et al.
The Journal of Biological Chemistry
|
January 24, 1998
Sulfated lewis X determinants as a major structural motif in glycans from LS174T-HM7 human colon carcinoma mucin
C Capon, J M Wieruszeski, J Lemoine, et al.
Oncogene
|
May 29, 2007
Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia
L Alinari, R Lapalombella, L Andritsos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 14, 1998
Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis
G W Wortmann, N E Aronson, J C Byrd, et al.
International Journal of Cancer
|
May 20, 1998
Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length
R S Bresalier, J C Byrd, P Brodt, et al.
Gastroenterology
|
August 1, 1997
Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients
J C Byrd, P Yan, L Sternberg, et al.
Cancer Research
|
September 15, 1999
Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers
G R Devi, A T De Souza, J C Byrd, et al.
The Journal of Biological Chemistry
|
August 14, 1999
Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations
J C Byrd, G R Devi, A T de Souza, et al.
Cell Death and Differentiation
|
September 24, 2011
Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells
N Mazurek, J C Byrd, Y Sun, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 188) with videos related to
Sort By:
Page
of 19
Leukemia Research
|
May 5, 2001
Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia
J K Waselenko, M R Grever, C A Shinn, et al.
Cancer
|
May 15, 1996
Anaphylactoid reactions to methotrexate
S A Alkins, J C Byrd, S K Morgan, et al.
The Journal of Biological Chemistry
|
January 24, 1998
Sulfated lewis X determinants as a major structural motif in glycans from LS174T-HM7 human colon carcinoma mucin
C Capon, J M Wieruszeski, J Lemoine, et al.
Oncogene
|
May 29, 2007
Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia
L Alinari, R Lapalombella, L Andritsos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 14, 1998
Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis
G W Wortmann, N E Aronson, J C Byrd, et al.
International Journal of Cancer
|
May 20, 1998
Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length
R S Bresalier, J C Byrd, P Brodt, et al.
Gastroenterology
|
August 1, 1997
Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients
J C Byrd, P Yan, L Sternberg, et al.
Cancer Research
|
September 15, 1999
Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers
G R Devi, A T De Souza, J C Byrd, et al.
The Journal of Biological Chemistry
|
August 14, 1999
Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations
J C Byrd, G R Devi, A T de Souza, et al.
Cell Death and Differentiation
|
September 24, 2011
Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells
N Mazurek, J C Byrd, Y Sun, et al.
Page
of 19